Abstract
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to widespread deposition of fibrin in the circulation. Recent knowledge on important pathogenetic mechanisms that may lead to DIC has resulted in novel preventive and therapeutic approaches to patients with DIC. The diagnosis of DIC can be made by sensitive laboratory tests; however, most of these tests are not readily available in a clinical setting. A reliable diagnosis can also be made on the basis of a small series of laboratory tests that can be combined in a scoring algorithm. The cornerstone of the management of DIC is the specific and vigorous treatment of the underlying disorder. Strategies aimed at the inhibition of coagulation activation may theoretically be justified and have been found beneficial in experimental and clinical studies. These strategies comprise inhibition of tissue factor-mediated activation of coagulation or restoration of physiological anticoagulant pathways.
Similar content being viewed by others
References
Levi M, Seligsohn U (2010) Disseminated intravascular coagulation. In: Kaushansky K, Lichtman M, Beutler E, Kipps T, Prchal J, Seligsohn U (eds) Williams hematology. McGraw Hill, Philadelphia
Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341:586–592
Levi M (2007) Disseminated intravascular coagulation. Crit Care Med 35:2191–2195
Levi M, van der Poll T (2010) Inflammation and coagulation. Crit Care Med 38:S26–S34
Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101:816–823
Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson BR, Brandt JT, Sundin D, Levi M (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924–1933
Levi M, Opal SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10:222
Anas AA, Wiersinga WJ, de Vos AF, van der Poll T (2010) Recent insights into the pathogenesis of bacterial sepsis. Neth J Med 68:147–152
Levi M, de Jonge E, van der Poll T (2001) Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 29(7 Suppl):S90–S94
Esmon CT (2001) Role of coagulation inhibitors in inflammation. Thromb Haemost 86(1):51–56
Levi M (2002) The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis. Crit Care Med 30:1914–1915
Lowenberg EC, Meijers JC, Levi M (2010) Platelet–vessel wall interaction in health and disease. Neth J Med 68:242–251
Osterud B (1998) Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 9(Suppl 1):S9–S14
Furie B, Furie BC (2004) Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 10:171–178
de Jonge E, Friederich PW, Levi M, van der Poll T (2003) Activation of coagulation by administration of recombinant factor VIIa elicits interleukin-6 and interleukin-8 release in healthy human subjects. Clin Diagn Lab Immunol 10:495–497
Levi M (2010) Disseminated intravascular coagulation: a disease-specific approach. Semin Thromb Hemost 36:363–365
Seligsohn U (2000) Disseminated intravascular coagulation. In: Handin RI, Lux SE, Stossel TP (eds) Blood: principles and practice of hematology. J.B.Lippingcott, Philadelphia
Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, Van Gorp EC (2003) Infections and endothelial cells. Cardiovasc Res 60:40–48
Gando S, Nakanishi Y, Tedo I (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23:1835–1842
Levi M (2009) Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res 123:S63–S64
Colman RW, Rubin RN (1990) Disseminated intravascular coagulation due to malignancy. Semin Oncol 17:172–186
Barbui T, Falanga A (2001) Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost 27:593–604
Fisher DF Jr, Yawn DH, Crawford ES (1983) Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg 118:1252–1255
Isbister GK (2010) Snake bite doesn’t cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 36:444–451
Levi M, Meijers JC (2011) DIC: which laboratory tests are most useful? Blood Rev 25:33–37
Dempfle CE, Borggrefe M (2008) Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 34:445–450
Toh CH, Samis J, Downey C, Walker J, Becker L, Brufatto N, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Ticknor LO, Paton R, Wenstone R, Nesheim M (2002) Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 100:2522–2529
Toh CH (2002) Transmittance waveform of routine coagulation tests is a sensitive and specific method for diagnosing non-overt disseminated intravascular coagulation. Blood Rev 16(Suppl 1):S11–S14
Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330
Toh CH, Hoots WK (2007) The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a five year overview. J Thromb Haemost 5:604–606
Wada H, Hatada T, Okamoto K, Uchiyama T, Kawasugi K, Mayumi T, Gando S, Kushimoto S, Seki Y, Madoiwa S, Okamura T, Toh CH (2010) Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC. Am J Hematol 85:691–694
Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H (1995) Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 74:848–852
Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S (2006) A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34:625–631
Sawamura A, Hayakawa M, Gando S, Kubota N, Sugano M, Wada T, Katabami K (2009) Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria for patients at an early phase of trauma. Thromb Res 124:706–710
Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR (2005) Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 33:341–348
Kinasewitz GT, Zein JG, Lee GL, Nazir SR, Taylor FB Jr (2005) Prognostic value of a simple evolving DIC score in patients with severe sepsis. Crit Care Med 33:221–225
Tromp M, Tjan DH, van Zanten AR, Gielen-Wijffels SE, Goekoop GJ, van den Boogaard M, Wallenborg CM, Biemond-Moeniralam HS, Pickkers P (2011) The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. Neth J Med 69:292–298
Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 145:24–33
Levi M, Levy M, Williams MD, Douglas I, Artigas A, Antonelli M, Wyncoll D, Janes J, Booth FV, Wang D, Sundin DP, Macias WL (2007) Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 176:483–490
Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869–1878
Afshari A, Wetterslev J, Brok J, Møller AM (2008) Antithrombin III for critically ill patients. Cochrane Database Syst Rev CD005370
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJJ (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699–709
Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, GÑrdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin Alfa (Activated) in adults with septic shock. N Engl J Med 366:2055–2064
Thachil J, Toh CH, Levi M, Watson HG (2012) The withdrawal of activated protein C from the use in patients with severe sepsis and DIC. Br J Haematol 157:493–494
Arul GS, Sacks L, Wolf A, Gargan M, Spicer RD (1998) Protein-C concentrate for meningococcal purpura fulminans. Lancet 351:988–989
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levi, M., van der Poll, T. Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med 8, 23–32 (2013). https://doi.org/10.1007/s11739-012-0859-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-012-0859-9